A phase 2 randomized, placebo-controlled crossover trial to evaluate safety and efficacy of platelet-rich plasma injections for Peyronie’s disease: clinical trial update-Reference-Cited by-同舟云学术

A phase 2 randomized, placebo-controlled crossover trial to evaluate safety and efficacy of platelet-rich plasma injections for Peyronie’s disease: clinical trial update

Published:2024-02-29 Issue: Volume: Page:
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Ledesma Braian R.^ORCID,Velasquez David A.^ORCID,Egemba Christabel^ORCID,Molina Manuel,Ibrahim Emad,Costantini-Mesquita Francesco,Deebel Nicholas A.,Han Sunwoo,Reis Isildinha M.,Saltzman Russell^ORCID,Ramasamy Ranjith

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41443-024-00844-3.pdf

Reference10 articles.

1. Brady L, Stender CJ, Wang YN, Schade GR, Maxwell AD, Wessells H, et al. Mechanical characterization of fibrotic and mineralized tissue in Peyronie’s disease. Int J Impot Res. 2022;34:477–86. https://doi.org/10.1038/s41443-021-00439-2.

2. American Urological Association. Peyronie’s Disease Guideline. 2021. Retrieved from https://www.auanet.org/guidelines/peyronies-disease-guideline.

3. European Association of Urology. Sexual and Reproductive Health - Penile Curvature. 2022. Retrieved from https://uroweb.org/guideline/sexual-and-reproductive-health/#6.

4. Zugail, AS, Alshuaibi, M, Lombion, S, Beley, S. Safety and feasibility of percutaneous needle tunneling with platelet-rich plasma injections for Peyronie’s disease in the outpatient setting: a pilot study. Int J Impot Res. 2023. https://doi.org/10.1038/s41443-023-00744-y.

5. Achraf C, Ammani AP, El Anzaoui J. Platelet-rich plasma in patients affected with Peyronie’s disease. Arab J Urol. 2022;21:69–75. https://doi.org/10.1080/2090598X.2022.2135284.